← FDA DRUG APPROVALS

FDA BLA · BLA761325

MERILOG

insulin aspart-szjj

Sponsor: SANOFI-AVENTIS U.S. LLC

APPLICATION
BLA761325
TYPE
BLA
ORIGINAL APPROVAL
2025-02-14
LATEST ACTION
2025-02-14
ROUTE
INTRAVENOUS, SUBCUTANEOUS, SOLUTION
DOSAGE FORM
INJECTION
MARKETING STATUS
Prescription

Products

MERILOGPrescription
INSULIN ASPART-SZJJ 10ML(100UNITS/ML) · INJECTION · SOLUTION
MERILOG SOLOSTARPrescription
INSULIN ASPART-SZJJ 3ML(100UNITS/ML) · INJECTION · SOLUTION

Approval history

2025-02-14UNKNOWN · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →